alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 266.1 Purpose and scope.

This part contains the rules that the Postal Service follows under the Privacy Act of 1974, 5 U.S.C. 552a. These rules should be read together with the Privacy Act, which provides additional information about records maintained on individuals. The rules in this part apply to all records in systems of records maintained by the Postal Service that are retrieved by an individual's name or personal identifier. They describe the procedures by which individuals may request notification of or access to records about themselves, request amendment of those records, and request an accounting of disclosures of those records by the Postal Service. In addition, the Postal Service processes all Privacy Act requests for access to records under the Freedom of Information Act (FOIA), 5 U.S.C. 552, following the rules contained in 39 CFR 265, as necessary, which provides the requester with the greatest access to his or her personal records.
Exhibit 32 (a)





CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with this Yearly Report of NMXS.com, Inc. (the "Company") on Form 10-KSB for the year ending December 31, 2004, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Richard Govatski, Chief Executive Officer of the Company, certifies to the best of his knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:



(1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





/s/ Richard Govatski

Richard Govatski

Chief Executive Officer



April 14, 2005
<PAGE>

                                  EXHIBIT 32.1


                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Allis-Chalmers
Corporation. (the "Company") for the period ended March 31, 2005, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of the operations of the Company.



DATE:  AUGUST 17, 2005              BY: /S/ MUNAWAR H. HIDAYATALLAH
                                        ---------------------------
                                        MUNAWAR H. HIDAYATALLAH
                                        CHIEF EXECUTIVE OFFICER


DATE:  AUGUST 17, 2005              BY: /S/ VICTOR M. PEREZ
                                        ---------------------------
                                        VICTOR M. PEREZ
                                        CHIEF FINANCIAL OFFICER
UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF FLORIDA

CASE NO. 22-MJ-8489-BER 

CASE NO. 22-MJ-8533-BER 

CASE NO. 22-MJ-8534-BER 

CASE NO. 22-MJ-8547-BER 

CASE NO. 22-MJ-8548-BER 

CASE NO. 22-MJ-8549-BER 

CASE NO. 22-MJ-8550-BER

IN RE SEALED SEARCH WARRANT

___________________________________/

UNITED STATES’ NOTICE OF FILING

Pursuant to the Court’s Omnibus Order of August 23, 2023, the United States of America

hereby provides notice of the filing of the attached partially redacted search warrant materials in 

the form approved by the Court in the Omnibus Order. 

Date: August 28, 2023

Respectfully submitted,

BRIAN M. BOYNTON

Principal Deputy Assistant Attorney General

Civil Division

ELIZABETH J. SHAPIRO

Deputy Director

Civil Division, Federal Programs Branch

/s/ Leslie Cooper Vigen

LESLIE COOPER VIGEN

Senior Trial Counsel (D.C. Bar No. 1019782)

United States Department of Justice

Civil Division, Federal Programs Branch

1100 L Street, NW

Washington, DC 20005

Tel.: (202) 305-0727

Email: Leslie.Vigen@usdoj.gov

Counsel for United States

Case 9:22-mj-08550-BER Document 14 Entered on FLSD Docket 08/28/2023 Page 1 of 1
!function(e,o,s){"use strict";o.behaviors.americorps={attach:function(o,t){var r=e("body");function n(){var e=document.querySelectorAll(".product-teaser-content .node__title");Array.prototype.forEach.call(e,(function(e){for(var o=e.querySelector("span"),s=e.clientHeight;o.offsetHeight>s;)o.textContent=o.textContent.replace(/\W*\s(\S)*$/,"...")}))}r.hasClass("d-theme-preceded")||(s("d_global_scrolled","html").length&&e(window).scroll().scroll((function(){e(this).scrollTop()>50?e("body").addClass("scrolled"):e("body").removeClass("scrolled")})),s("d_global_resize","html").length&&e(window).resize((function(){n()})),n(),e("#header .dropdown, .language-switcher-language-url").hover((function(){e(this).addClass("force-show"),e(this).find(".dropdown-menu").addClass("force-show")}),(function(){e(this).removeClass("force-show").removeClass("show"),e(this).find(".dropdown-menu").removeClass("force-show").removeClass("show")})),e(".menu-dropdown-icon").on({touchstart:function(){e(this).parent().removeClass("force-show"),e(this).parent().find(".dropdown-menu").removeClass("force-show")}}),r.addClass("d-theme-preceded"))}},o.behaviors.droopler_unpublished={attach:function(s,t){e("<div>").addClass("unpublished-message").text(o.t("Unpublished")).insertBefore(e(".node--unpublished",s))}}}(jQuery,Drupal,once);
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

JOSE MANUEL ALONSO ZARAGOZA, 

Petitioner, 

 v. 

MERRICK B. GARLAND, Attorney 

General, 

Respondent.

No. 18-72676 

Agency No. A073-938-744 

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted March 14, 2023**

Before: SILVERMAN, SUNG, and SANCHEZ, Circuit Judges. 

Jose Manuel Alonso Zaragoza, a native and citizen of Mexico, petitions for 

review of the Board of Immigration Appeals’ (“BIA”) order denying his motion to 

reopen his reinstated deportation order. We have jurisdiction under 8 U.S.C. 

§ 1252. We deny the petition for review.

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2).

FILED

MAR 17 2023

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 18-72676 

Because a prior deportation order that has been reinstated “is not subject to

being reopened or reviewed,” 8 U.S.C. § 1231(a)(5), the BIA lacked jurisdiction to 

consider Alonso Zaragoza’s motion to reopen, see Gutierrez-Zavala v. Garland,

32 F.4th 806, 811 (9th Cir. 2022) (“When the BIA denies a motion to reopen a

reinstated removal order on grounds other than a lack of jurisdiction, we may deny

a petition challenging that ruling based on the BIA’s lack of jurisdiction under

8 U.S.C. § 1231(a)(5).”); Bravo-Bravo v. Garland, 54 F.4th 634, 641 (9th Cir. 

2022) (“[U]nder § 1231(a)(5), an alien’s prior removal order and proceedings are 

not subject to being reopened, and the regulation providing the BIA’s sua sponte

reopening authority cannot override that command.” (internal quotation marks and 

citation omitted)); Reyes v. Garland, 11 F.4th 985, 990-91 (9th Cir. 2021) (unlike 

legislation, judicial decisions are “governed by a fundamental rule of retrospective 

operation” (internal quotation marks and citation omitted)). 

Because this determination is dispositive of his claim, we do not address 

Alonso Zaragoza’s remaining contentions. See Simeonov v. Ashcroft, 371 F.3d 

532, 538 (9th Cir. 2004) (courts are not required to decide issues unnecessary to 

the results they reach).

PETITION FOR REVIEW DENIED.
§ 102-36.475 What is the authority for transfers under “Computers for Learning”? ( a ) The Stevenson-Wydler Technology Innovation Act of 1980, as amended (15 U.S.C. 3710(i)), authorizes federal agencies to transfer excess education-related federal equipment to educational institutions or nonprofit organizations for educational and research activities. Executive Order 12999 (3 CFR, 1996 Comp., p. 180) requires, to the extent permitted by law and where appropriate, the transfer of computer equipment for use by schools or nonprofit organizations.
( b ) Each federal agency is required to identify a point of contact within the agency to assist eligible recipients, and to publicize the availability of such property to eligible communities. Excess education-related equipment may be transferred directly under established agency procedures, or reported to GSA as excess for subsequent transfer to potential eligible recipients as appropriate. You must include transfers under this authority in the annual Non-federal Recipients Report (See § 102-36.295) to GSA.
( c ) The “Computers for Learning” website has been developed to streamline the transfer of excess and surplus Federal computer equipment to schools and nonprofit educational organizations. For additional information about this program access the “Computers for Learning” website, *http://www.computers.fed.gov .*
#### § 102-42.55 What does the employing agency do with the appraisal?

When an appraisal is necessary under § 102-42.40, the employing agency must include the appraisal with the Standard Form (SF) 120, Report of Excess Personal Property, and send it to GSA in accordance with the requirements of § 102-42.95. By attaching the appraisal, the employing agency is certifying that the value cited is the retail value/appraised value of the item in the United States in U.S. dollars on the date set forth on the appraisal.

[74 FR 2396, Jan. 15, 2009]
<TABLE> <S> <C>

<ARTICLE>  7
       
<S>                                 <C>
<PERIOD-TYPE>                       9-MOS
<FISCAL-YEAR-END>                                DEC-31-1998
<PERIOD-END>                                     SEP-30-1998
<DEBT-HELD-FOR-SALE>                                 209,852
<DEBT-CARRYING-VALUE>                                    484
<DEBT-MARKET-VALUE>                                      540
<EQUITIES>                                               447
<MORTGAGE>                                                 0
<REAL-ESTATE>                                              0
<TOTAL-INVEST>                                       242,093
<CASH>                                                 2,108
<RECOVER-REINSURE>                                   284,636
<DEFERRED-ACQUISITION>                                 6,329
<TOTAL-ASSETS>                                       611,971
<POLICY-LOSSES>                                      421,727
<UNEARNED-PREMIUMS>                                   75,593
<POLICY-OTHER>                                             0
<POLICY-HOLDER-FUNDS>                                      0
<NOTES-PAYABLE>                                            0
<PREFERRED-MANDATORY>                                      0
<PREFERRED>                                                0
<COMMON>                                               7,079
<OTHER-SE>                                            74,546
<TOTAL-LIABILITY-AND-EQUITY>                         611,971
<PREMIUMS>                                            52,403
<INVESTMENT-INCOME>                                   11,765
<INVESTMENT-GAINS>                                       955
<OTHER-INCOME>                                         3,072
<BENEFITS>                                            46,720
<UNDERWRITING-AMORTIZATION>                           10,374
<UNDERWRITING-OTHER>                                   6,294
<INCOME-PRETAX>                                       (1,151)
<INCOME-TAX>                                            (400)
<INCOME-CONTINUING>                                     (751)
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                            (751)
<EPS-PRIMARY>                                          (0.11)
<EPS-DILUTED>                                          (0.11)
<RESERVE-OPEN>                                             0
<PROVISION-CURRENT>                                        0
<PROVISION-PRIOR>                                          0
<PAYMENTS-CURRENT>                                         0
<PAYMENTS-PRIOR>                                           0
<RESERVE-CLOSE>                                            0
<CUMULATIVE-DEFICIENCY>                                    0
        

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Initial Review Group, Mental Retardation Research Subcommittee.                    

*Date:*                         June 15-16, 2000.                    

*Time:*                         8:00 AM to 5:00 PM.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Norman Chang, Scientific Review Administrator, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.209, Contraception and Infertility Loan Repayment Program; 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research, National Institutes of Health, HHS)

Dated: June 13, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-15751 Filed 6-21-00; 8:45 am]

BILLING CODE 4140-01-M
EXHIBIT 2.9





SECOND AMENDMENT TO ASSET PURCHASE AGREEMENT





This SECOND AMENDMENT TO ASSET
PURCHASE AGREEMENT (Amendment), made as of this 20th day of July, 2001, by and between BAXTER HEALTHCARE CORPORATION, a Delaware corporation with offices at 1627 Lake Cook Road, Deerfield, Illinois 60015 (the Seller), and
GENSTAR THERAPEUTICS CORPORATION, a Delaware corporation with offices at 10835 Altman Row, Suite A, San Diego, California, 92121 (Buyer).





RECITALS





WHEREAS, the Buyer and the Seller have entered into that certain Asset Purchase
Agreement, dated as of February 28, 1998, as amended by the Amendment to Asset Purchase Agreement dated May 27, 1998 (the Agreement); and





WHEREAS, the Buyer and the Seller desire to amend the Agreement to update the name of the Buyer after a change in the name of Buyer and to reflect certain changes to terms of the Series A Preferred Stock,
Series B Preferred Stock and Series C Preferred Stock of Buyer, upon and subject to the terms and conditions of this Amendment; and





WHEREAS, any capitalized terms not otherwise defined in this Amendment shall bear the meaning ascribed to such terms in the Agreement.





NOW THEREFORE, in consideration of the mutual covenants and promises herein contained, the parties agree as follows:





As of the date hereof, the Agreement is hereby amended to update the name of Buyer from UROGEN CORP. to GENSTAR THERAPEUTICS CORPORATION and to replace the Certificates of Designation for the Series A Preferred Stock,
Series B Preferred Stock and Series C Preferred Stock of Buyer as contained in  Exhibit A of the Agreement with the form attached hereto as Exhibit 1.





IN WITNESS WHEREOF, the parties hereto have executed this Amendment, as of the date first above written.





SELLER:BAXTER HEALTHCARE CORPORATIONBy:Title:

President, Venture ManagementVictor W. Schmitt





BUYER:GENSTAR THERAPEUTICS CORPORATIONBy:Title:

Chief Executive OfficerRobert E. Sobol, M.D.









---




EXHIBIT 1





[Certificates of Designation for


Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock]
Exhibit 31.2


I, James A. Beer, certify that:

1. I  have  reviewed this quarterly report on Form 10-Q of American
   Airlines, Inc.;

2. Based  on my knowledge, this report does not contain any  untrue
   statement  of  a  material fact or omit to  state  a  material  fact
   necessary to make the statements made, in light of the circumstances
   under which such statements were made, not misleading with respect to
   the period covered by this report;

3. Based  on  my  knowledge, the financial  statements,  and  other
   financial information included in this report, fairly present in all
   material respects the financial condition, results of operations and
   cash flows of the registrant as of, and for, the periods presented in
   this report;

4. The   registrant's  other  certifying  officer(s)  and  I   are
   responsible for establishing and maintaining disclosure controls and
   procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
   for the registrant and have:

   (a) Designed such disclosure controls and procedures, or caused such
       disclosure controls and procedures to be designed under our
       supervision, to ensure that material information relating to the
       registrant, including its consolidated subsidiaries, is made known to
       us by others within those entities, particularly during the period in
       which this report is being prepared;

   (b) Evaluated the effectiveness of the registrant's disclosure
       controls and procedures and presented in this report our conclusions
       about the effectiveness of the disclosure controls and procedures, as
       of the end of the period covered by this report based on such
       evaluation; and

   (c) Disclosed in this report any change in the registrant's internal
       control over financial reporting that occurred during the registrant's
       most recent fiscal quarter (the registrant's fourth fiscal quarter in
       the case of an annual report) that has materially affected, or is
       reasonably likely to materially affect, the registrant's internal
       control over financial reporting; and

5. The   registrant's  other  certifying  officer(s)  and  I  have
   disclosed,  based on our most recent evaluation of internal  control
   over financial reporting, to the registrant's auditors and the audit
   committee  of  the  registrant's  board  of  directors  (or  persons
   performing the equivalent functions):

   (a) All significant deficiencies and material weaknesses in the
       design or operation of internal control over financial reporting which
       are reasonably likely to adversely affect the registrant's ability to
       record, process, summarize and report financial information; and

   (b) Any fraud, whether or not material, that involves management or
       other employees who have a significant role in the registrant's
       internal control over financial reporting.



Date:  October 21, 2004            /s/ James A. Beer
                                   James A. Beer
                                   Senior Vice President and Chief
                                   Financial Officer
§ 105-68.205 Why is it important if a particular transaction is a covered transaction? The importance of a covered transaction depends upon who you are. ( a ) As a participant in the transaction, you have the responsibilities laid out in subpart C of this part. Those include responsibilities to the person or Federal agency at the next higher tier from whom you received the transaction, if any. They also include responsibilities if you subsequently enter into other covered transactions with persons at the next lower tier.
( b ) As a Federal official who enters into a primary tier transaction, you have the responsibilities laid out in subpart D of this part.
( c ) As an excluded person, you may not be a participant or principal in the transaction unless— ( 1 ) The person who entered into the transaction with you allows you to continue your involvement in a transaction that predates your exclusion, as permitted under § 105-68.310 or § 105-68.415; or
( 2 ) A(n) GSA official obtains an exception from the Administrator of General Services to allow you to be involved in the transaction, as permitted under § 105-68.120.
Case 1:22-cv-24066-KMM Document 196-3 Entered on FLSD Docket 06/10/2024 Page 1 of 6
Case 1:22-cv-24066-KMM Document 196-3 Entered on FLSD Docket 06/10/2024 Page 2 of 6
Case 1:22-cv-24066-KMM Document 196-3 Entered on FLSD Docket 06/10/2024 Page 3 of 6
Case 1:22-cv-24066-KMM Document 196-3 Entered on FLSD Docket 06/10/2024 Page 4 of 6
Case 1:22-cv-24066-KMM Document 196-3 Entered on FLSD Docket 06/10/2024 Page 5 of 6
Case 1:22-cv-24066-KMM Document 196-3 Entered on FLSD Docket 06/10/2024 Page 6 of 6